Zepp Health (ZEPP) has had the highest return since January 1, 2025 by a small-cap US stock, returning 1,396.2%.
| ASSET | % RETURN |
|---|---|
Zepp Health (ZEPP) | 1,396.15% |
Oncology Institute (TOI) | 1,367.32% |
DeFi Development (DFDV) | 1,320.72% |
Newegg Commerce (NEGG) | 955.63% |
180 Life Sciences (ATNF) | 838.55% |
Better Home & Finance (BETR) | 696.72% |
Palvella Therapeutics (PVLA) | 561.84% |
ThredUp (TDUP) | 490.28% |
Nanobiotix (NBTX) | 469.13% |
I-Mab (IMAB) | 455.89% |
Inhibrx Biosciences (INBX) | 431.94% |
Avino Silver & Gold Mines (ASM) | 418.68% |
IsoEnergy (ISOU) | 410.16% |
Lightbridge (LTBR) | 401.62% |
Amprius Technologies (AMPX) | 370.83% |
Mobilicom Limited Warrants (MOBBW) | 359.82% |
Galectin Therapeutics (GALT) | 358.02% |
American Resources Corp Class A (AREC) | 344.44% |
So-Young International (SY) | 343.11% |
Claritev (CTEV) | 335.45% |
DBV Technologies (DBVT) | 333.13% |
Xunlei Ltd Adr (XNET) | 326.96% |
Nektar Therapeutics (NKTR) | 316.11% |
Nutex Health (NUTX) | 311.21% |
NioCorp Developments Ltd Common Stock (NB) | 310.69% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
